World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
110
Citations
42093
World Ranking
506
National Ranking
306

Medicine

D-Index
110
Citations
42122
World Ranking
5591
National Ranking
3007

Emma Guttman-Yassky publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Emma Guttman-Yassky sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 382 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Emma Guttman-Yassky D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Emma Guttman-Yassky sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 110 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Emma Guttman-Yassky is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily focuses on the field of Medicine, with a significant emphasis on Dermatology, Immunology, Allergy, Physiology, and Rheumatology.

The scientist's main areas of study include:

  • Dermatology and Skin Diseases
  • Allergic Rhinitis and Sensitization
  • Asthma and respiratory diseases
  • Food Allergy and Anaphylaxis Research
  • Urticaria and Related Conditions
  • IL-33, ST2, and ILC Pathways
  • Hair Growth and Disorders

Emma Guttman-Yassky has contributed to numerous publications found predominantly in the following venues:

  • Journal of Investigative Dermatology
  • Journal of the American Academy of Dermatology
  • Allergy
  • Journal of Allergy and Clinical Immunology
  • British Journal of Dermatology

Some of their recent significant papers include:

  • "Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)*" (2020, British Journal of Dermatology)
  • "Type 2 immunity in the skin and lungs" (2020, Allergy)
  • "Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials" (2021, The Lancet)
  • "Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis" (2020, Journal of Allergy and Clinical Immunology)
  • "Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials" (2020, British Journal of Dermatology)

Their collaborative network includes frequent co-authorship with:

  • Ester Del Duca
  • Yeriel Estrada
  • Jonathan I. Silverberg
  • James G. Krueger
  • Eric L. Simpson

The broad thematic span of their work engages with immune-related mechanisms, especially within the context of dermatological and allergic diseases. The volume and venues of publication indicate an active role in advancing understanding in areas such as atopic dermatitis, immune system pathways, and related clinical interventions.

Best Publications

  • Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

    Eric L. Simpson;Thomas Bieber;Emma Guttman-Yassky;Lisa A. Beck

  • Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.

    Lisa A. Beck;Diamant Thaçi;Jennifer D. Hamilton;Neil M. Graham

  • Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis.

    Julia K. Gittler;Julia K. Gittler;Avner Shemer;Mayte Suárez-Fariñas;Judilyn Fuentes-Duculan

  • Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.

    K.E. Nograles;L.C. Zaba;E. Guttman-Yassky;J. Fuentes-Duculan

  • IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells

    Kristine E. Nograles;Lisa C. Zaba;Avner Shemer;Judilyn Fuentes-Duculan

  • Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis

    Andrea Chiricozzi;Emma Guttman-Yassky;Emma Guttman-Yassky;Mayte Suárez-Fariñas;Kristine E. Nograles

  • The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies

    Patrick M. Brunner;Emma Guttman-Yassky;Donald Y.M. Leung

  • Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis

    Emma Guttman-Yassky;Emma Guttman-Yassky;Robert Bissonnette;Benjamin Ungar;Benjamin Ungar;Mayte Suárez-Fariñas

  • The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.

    Shinji Noda;Mayte Suárez-Fariñas;Benjamin Ungar;Benjamin Ungar;Soo Jung Kim

  • Atopic dermatitis endotypes and implications for targeted therapeutics.

    Tali Czarnowicki;Helen He;James G. Krueger;Emma Guttman-Yassky;Emma Guttman-Yassky

  • Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

    Thomas Werfel;Jean-Pierre Allam;Tilo Biedermann;Kilian Eyerich

  • Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

    A. Wollenberg;A. Blauvelt;E. Guttman‐Yassky;M. Worm

  • Deciphering the Complexities of Atopic Dermatitis: Shifting Paradigms in Treatment Approaches

    Donald Y.M. Leung;Emma Guttman-Yassky

  • Type 2 immunity in the skin and lungs.

    Cezmi A. Akdis;Peter D. Arkwright;Marie-Charlotte Brüggen;William Busse

  • Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.

    Eric L. Simpson;Amy S. Paller;Elaine C. Siegfried;Mark Boguniewicz

  • Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.

    Jennifer D. Hamilton;Mayte Suárez-Fariñas;Nikhil Dhingra;Irma Cardinale

  • Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis

    Mayte Suárez-Fariñas;Nikhil Dhingra;Nikhil Dhingra;Julia Gittler;Julia Gittler;Avner Shemer

  • Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities.

    Mayte Suárez-Fariñas;Suzanne J. Tintle;Avner Shemer;Andrea Chiricozzi;Andrea Chiricozzi

  • Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

    Emma Guttman-Yassky;Henrique D. Teixeira;Eric L. Simpson;Kim A. Papp

  • Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb.

    Andreas Wollenberg;Michael D. Howell;Emma Guttman-Yassky;Jonathan I. Silverberg

  • Contrasting pathogenesis of atopic dermatitis and psoriasis—Part I: Clinical and pathologic concepts

    Emma Guttman-Yassky;Emma Guttman-Yassky;Kristine E. Nograles;James G. Krueger

Frequent Co-Authors

James G. Krueger
James G. Krueger Rockefeller University
Mayte Suárez-Fariñas
Mayte Suárez-Fariñas Icahn School of Medicine at Mount Sinai
Eric L. Simpson
Eric L. Simpson Oregon Health & Science University
Judilyn Fuentes-Duculan
Judilyn Fuentes-Duculan Rockefeller University
Jonathan I. Silverberg
Jonathan I. Silverberg George Washington University Hospital
Amy S. Paller
Amy S. Paller Northwestern University
Lisa A. Beck
Lisa A. Beck University of Rochester Medical Center
Lawrence F. Eichenfield
Lawrence F. Eichenfield University of California, San Diego
Mark Lebwohl
Mark Lebwohl Icahn School of Medicine at Mount Sinai
Kenji Kabashima
Kenji Kabashima Kyoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology often opens doors to various healthcare and research careers. For those interested in clinical practice, pursuing a nursing path can be a rewarding option. Programs like the easiest nurse practitioner program provide flexible routes to entering the field without compromising quality.

Specialties such as psychiatric mental health nursing are increasingly in demand. Prospective students should consider accredited options like the top pmhnp programs, which emphasize strong clinical placements, essential for hands-on experience.

Budget-conscious learners can find value through the cheapest psychiatric nurse practitioner programs, which offer quality education at a lower cost, helping to ease financial barriers while maintaining rigorous training standards.

Advancing education to the doctoral level also impacts earning potential. Insights into the doctorate in nursing salary provide valuable context for understanding the financial benefits of higher nursing degrees, informing long-term career planning.

Best Scientists Citing Emma Guttman-Yassky

Trending Scientists

Recently Published Articles